Skip To Main Content
L. Curto‐Barredo on Muck Rack

L. Curto‐Barredo

As seen in: Color Research & Application
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with L.

Contact L., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria

|
By J. Spertino, V. Expósito‐Serrano, L. Curto‐Barredo, I. Figueras‐Nart
| Color Research & Application Verified
Funding sources: no external funding. Conflicts of interest: L.C.‐B., I.F.‐N. and E.S.‐B. have received lecture fees or research grant from Novartis. A.G.‐A. is Medical Advisor for Novartis and has received lecture fees and research grant from Novartis. J.S., V.E.‐S., G.M.‐N., J.G.‐L., X.G.‐N., G.A. and M. Villar have received lecture fees from Novartis. A.G., X.C., I.B.‐M., M.B.‐O., M. Vilavella, C.B.‐P., A.Á., N.L.‐D. and X.D.‐J. have no conflicts of interest.
Open in Who Shared Issue with article?

Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria

|
By L. Curto‐Barredo, J. Spertino, I. Figueras‐Nart, V. Expósito‐Serrano
| Color Research & Application Verified
Funding sources: no external funding. Conflicts of interest: L.C.‐B., I.F.‐N. and E.S.‐B. have received lecture fees or research grant from Novartis. A.G.‐A. is Medical Advisor for Novartis and has received lecture fees and research grant from Novartis. J.S., V.E.‐S., G.M.‐N., J.G.‐L., X.G.‐N., G.A. and M. Villar have received lecture fees from Novartis. A.G., X.C., I.B.‐M., M.B.‐O., M. Vilavella, C.B.‐P., A.Á., N.L.‐D. and X.D.‐J. have no conflicts of interest.
Open in Who Shared Issue with article?
See all 2 articles